Synthetech, Inc., a fine chemicals company, specializes in organic synthesis, biocatalysis, and chiral technologies. The company develops and manufactures proprietary custom chiral intermediates, amino acid derivatives, specialty amino acids, peptide fragments, and specialty resins primarily for the pharmaceutical industry, as well as produces pharmaceutical intermediates. Synthetech?s products are used in the development and manufacture of therapeutic peptides and peptidomimetic small molecule drugs at various stages of a customer?s clinical development pipeline, and are used as ingredients in drugs for the treatment of AIDS, cancer, cardiovascular, and other diseases. Its products also support the production of chemically based medical devices. The company serves pharmaceutical companies, contract drug synthesis firms, and biopharmaceutical and medical device companies. It sells its products directly, as well as through independent sales representatives primarily in Europe, the United States, Canada, and Japan. The company was founded in 1981 and is headquartered in Albany, Oregon.